The COVID-19 pandemic—despite the vaccination drives and precautionary measures—is still haunting the world. After the disastrous consequences of Delta and Delta plus variants, the new omicron variant is adding to the concern for countries around the world. Although numerous people around the world have completed their dosage of the vaccine, the omicron threat is making […]
Comparison between first and second wave The COVID-19 second wave is spreading rapidly in India and cases are continuously rising. India reported 68,020 new infections, it was counted as the highest number of cases since last year October 2020. Currently, the number of COVID cases in the country has reached 12-million. These cases are mostly
In detail analysis of Second wave of COVID-19 in India Read More »
The impact of the COVID-19 pandemic was devastating for economies around the world. Generally known as developing economies, the Asian countries also suffered through severe challenges during the crisis. While giant Asian economies such as India, Japan, and South Korea saw a major decline in their growth rate, a small economy like Vietnam has outperformed
Why is Vietnam the Top-performing Economy during the COVID-19 Pandemic? Read More »
The World Health Organization leads an international team of scientists who arrived in China’s central city of Wuhan for COVID-19 origins investigation. They are expected to investigate the origins of the novel coronavirus that sparked the pandemic. The team arrived late in the morning from Singapore and was likely to head into two weeks of
WHO team reaches in Wuhan for investigating COVID-19 origins Read More »
India will begin the exporting of the locally made COVID-19 vaccine after the immediate launch of the vaccines. If there is a shortage of vaccines to meet local demand, the country will ban exporting the same. India is about to make 60% of the vaccine produces and many countries are eagerly waiting for the vaccine
India to export Covid-19 vaccines ‘within weeks’ of production Read More »
Up to 20 people who had recently returned from the UK have been detected to be carrying the mutant strain of the new COVID-19 variant (SARS-CoV-2). The new covid-19 variant has caused a surge of panic across countries with its 70% higher transmission rate. Countries have closed their borders in anticipation of the mutated COVID-19
India Faces 20 Cases of New COVID-19 Variant So Far Read More »
Pfizer’s COVID-19 vaccine: Pfizer’s COVID-19 vaccine Applied for the emergency use authorization of its coronavirus vaccine in India. It is the first company to do so as India is the second-highest number of infections in the world. The recently approved Britain vaccine approached Indian authorities on Saturday. VK Paul said on Saturday, “We welcome interest from
India approves the urgent appeal made by Pfizer’s COVID-19 vaccine? Read More »
Moderna, a US-based pharmaceutical company has applied to the FDA authorization of its covid-19 vaccine. The company has asked the US FDA for authorization to administer the drug to patients after a review of its expanded data. According to recent news reports, the company’s vaccine is 94.1% effective at immunization. Moreover, the company also claims
Moderna Animates Race for First Covid-19 Vaccine Read More »
CoronaVac, the experimental COVID-19 vaccine made by Sinovac Biotech, triggered a quick immune response, however; the levels of the antibodies produced were drastically reduced in people who had recovered from the disease. Researches have put forth that the CoronaVac could provide sufficient protection, based on their experience with other vaccines and data from preclinical studies
‘Sinovac’ Moving Forward in the COVID-19 Vaccine Race Read More »
US-based pharma company Pfizer Inc and German Biotech company BioNTech announced that their mRNA-based COVID vaccine candidate, BNT162b2, has demonstrated evidence of efficacy against COVID-19 in patients. The first interim efficacy analysis conducted on November 8, 2020, by an external, independent Data Monitoring Committee (DMC), stated this from the Phase 3 clinical trial. Pfizer said
Pfizer and BioNTech declares their COVID-19 vaccine is over 90% effective Read More »
